How AI Is Being Used to Accelerate Clinical Trials

Artificial intelligence (AI) has already been used to make strong inroads into the early stages of drug discovery, assisting in the search for suitable disease targets and new molecule designs. Now scientists are starting to use AI to manage clinical trials, including the tasks of writing protocols, recruiting patients and analysing data. Reforming clinical research is “a big topic of interest in the industry”, says Lisa Moneymaker, the chief technology officer and chief product officer at Saama, a software company in Campbell, California, that uses AI to help organizations automate parts of clinical trials. “In terms of applications,” she says, “it’s like a kid in a candy store.”

Read the full article: How AI Is Being Used to Accelerate Clinical Trials //

Source: https://www.nature.com/articles/d41586-024-00753-x

Leave a Comment

Your email address will not be published.

Scroll to Top